Etanercept (ETN) is a completely human fusion TNF-soluble receptor that inhibits the effect of the proinflammatory cytokine TNF-α, which has an important role in synovitis and joint damage in rheumatoid arthritis (RA) [13]. This evidence concerns the gene TNF and rheumatoid arthritis.